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Transcriptional coactivator with PDZ-binding motif (TAZ) physically interacts with a variety of transcription factors andmodu-
lates their activities involved in cell proliferation andmesenchymal stem cell differentiation. TAZ is highly expressed in the kid-
ney, and a deficiency of this protein results in multiple renal cysts and urinary concentration defects; however, the molecular
functions of TAZ in renal cells remain largely unknown. In this study, we examined the effects of osmotic stress on TAZ expres-
sion and activity in renal cells. We found that hyperosmotic stress selectively increased protein phosphorylation at tyrosine 316
of TAZ and that this was enhanced by c-Abl activation in response to hyperosmotic stress. Interestingly, phosphorylated TAZ
physically interacted with nuclear factor of activated T cells 5 (NFAT5), a major osmoregulatory transcription factor, and subse-
quently suppressed DNA binding and transcriptional activity of NFAT5. Furthermore, TAZ deficiency elicited an increase in
NFAT5 activity in vitro and in vivo, which then reverted to basal levels following restoration of wild-type TAZ but not mutant
TAZ (Y316F). Collectively, the data suggest that TAZmodulates cellular responses to hyperosmotic stress through fine-tuning of
NFAT5 activity via tyrosine phosphorylation.
Transcriptional coactivator with PDZ-binding motif (TAZ), alsoknown as WW domain-containing transcription regulator 1
(WWTR1), was first identified as a 14-3-3-interacting phosphopro-
tein (16). Phosphorylation of TAZ at serine 89 is required for its
interactionwith14-3-3 and for substantial retention in the cytoplasm
(16). In addition to the 14-3-3-bindingmotif, TAZ containsmultiple
functional domains, including aWWdomain, a coiled-coil domain,
and a PDZ-bindingmotif, throughwhich itmodulates the activity of
transcription factors involved in stem cell differentiation (13). For
example, TAZ interacts with runt-related transcription factor 2
(RUNX2)andMyoDduringosteoblast andmyogenicdifferentiation
andpromotes cell lineage-specificgene transcription (6, 13, 15).Dur-
ing adipogenic differentiation, TAZ suppresses the activity of perox-
isome proliferator-activated receptor (PPAR), thus inhibiting adipo-
genic differentiation from mesenchymal stem cells (13). TAZ also
controls organ development, including thyroid, cardiac, and limb
development, by association with thyroid transcription factor 1
(TTF-1), paired box gene 8 (PAX8), and PAX3 (7, 28–30). Further-
more, TAZ promotes cell proliferation through activation of TEAD
transcription factors, resulting in tumor cell growth and epithelial-
mesenchymal transition(4,5,19,22,37).Muchofourunderstanding
of the physiological function of TAZ in vivo has been derived from
studies using TAZ knockout (KO) mice, which develop significant
pathogenic phenotypes, such as lung emphysema and multiple kid-
ney cysts (14, 24). Although the pathogenic mechanisms at play in
TAZ KOmice largely remain to be explored, TAZ is known to sup-
press the expression and activity of the transmembrane protein poly-
cystin 2 (PC2) in thekidney (8, 33). IncreasedPC2expression inTAZ
KO mice may be involved in the development of polycystic kidney
disease (33). In addition, TAZ interacts with the transcription factor
Glis-3 and enhances its transcriptional activity. It is evident that defi-
ciency of either TAZ or Glis-3 in mice leads to abnormal cilium for-
mation and topolycystic kidneys (17).Collectively, these studies sug-
gest that TAZ plays critical roles in normal kidney development and
function through different mechanisms.
Since hyperosmolar medullary interstitial fluid is essential for
urinary concentration in the kidney, renalmedullary cells are nor-
mally exposed to extracellular hyperosmotic stress, which can
cause cell shrinkage, DNA damage, and cell apoptosis. To avoid
hyperosmotic stress-induced damage, renal medullary cells ex-
hibit rapid adjustment via a complex network of osmoprotective
molecules, including kinases, heat shock proteins, p53, and
osmolyte-accumulating genes (2). The osmolyte-accumulating
genes include those encoding the betaine-GABA transporter
(BGT1) (35) and the sodium/myo-inositol cotransporter (SMIT)
(34, 36). Induction of these genes results in organic osmolyte ac-
cumulation, which prevents acute hyperosmotic stress-induced
water loss and cell shrinkage. Expression of BGT1 and SMIT is
transcriptionally controlled by the nuclear factor of activated T
cells 5 (NFAT5)/tonicity-responsive enhancer-binding protein
(TonEBP), referred to here as NFAT5 (10, 26, 27). NFAT5 defi-
ciency blocks the expression of osmolyte-accumulating genes in
the kidney medulla and produces a severe urinary concentration
defect in mice, suggesting a critical role for NFAT5 in the hyper-
osmotic stress signaling pathway (21). However, recent studies
indicate that NFAT5 is activated by various tonicity-independent
mechanisms and exhibits tissue-specific functions, such as cell
migration, vascular remodeling, and carcinoma invasion (12). Al-
though the hyperosmolarity-dependent and -independent activa-
tion and functions of NFAT5 have been characterized extensively
for numerous cell types, mechanisms underlying the suppression
of NFAT5 activity remain unclear.
In this study, we investigated the effects of hyperosmotic stress
on TAZ activity and its relationship with NFAT5 function in renal
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medullary cells. Interestingly, TAZunderwent tyrosine phosphor-
ylation in response to hyperosmotic stress and specifically associ-
ated with NFAT5, suppressing its DNA-binding activity and tran-
scriptional activity. Our results suggest that TAZ functions as a
modulator of NFAT activity in response to hyperosmotic stress.
MATERIALS AND METHODS
Reagents. Antibodies (Abs) against phosphorylated serine 89 of TAZ
(pS89), TAZ, Oct1, -actin, phospho-Abl (pAbl), phosphotyrosine (pY;
4G10), c-Abl, and NFAT5 were purchased from Santa Cruz Biotechnol-
ogy, Inc. (Santa Cruz, CA), Cell Signaling Technology (Boston, MA),
Upstate Biotechnology Inc. (Lake Placid, NY), and Abcam Inc. (Cam-
bridge, MA). Flag Ab and Flag-M2 agarose beads were purchased from
Sigma-Aldrich (St. Louis, MO). Recombinant c-Abl kinase and imatinib
(STI-571) were obtained fromCalbiochem (SanDiego, CA) andNovartis
Pharmaceuticals (Basel, Switzerland), respectively. Abs recognizing phos-
photyrosine (pY118, pY141, pY300, and pY316) were generated by Ab-
Frontier Inc. (Seoul, Republic of Korea).
Animals. Wild-type (WT) C57BL/6 mice were purchased from Jack-
son Laboratories (Bar Harbor, ME). WT and TAZ KO mice were main-
tained under specific-pathogen-free conditions. All animal experiments
were performed in accordancewith IACUCguidelines andwere approved
by the IACUC at Ewha Womans University (protocols ELAGC-09-1017
and IACUC 2010-13-3).
Cell culture. Cos7 and HEK293T cells were obtained from the Amer-
ican Type Culture Collection (ATCC, Manassas, VA) and cultured in
Dulbecco’s modified Eagle medium (DMEM; Invitrogen, Carlsbad, CA).
Cells were transiently transfected by calcium phosphate transfection
methods. Tonicity-responsive immortalized mouse inner medullary col-
lecting duct 3 cells (mIMCD-3 cells; ATCC) andmouse embryonic fibro-
blasts (MEF) of WT and TAZ KO mice were maintained in DMEM sup-
plemented with 10% heat-inactivated fetal bovine serum (FBS; HyClone,
Logan, UT). Cells were exposed to low-salt, normal, or hyperosmolar
medium (final osmolarity, 150, 300, or 400 mosmol/kg H2O) for 2 to 4 h
by use of NaCl. For hyperosmotic stimulation, cells were exposed to low-
salt (150 mosmol/kg H2O) conditions for 2 h and subsequently cultured
in normal or hyperosmolar medium for 4 h.
In situ PLA. Renal mIMCD-3 cells were plated onto a glass slide and
incubated in normal or hyperosmotic medium for 4 h. Cells were fixed
and incubated with mouse anti-TAZ Ab (1:100; Abcam) and rabbit anti-
NFAT5Ab (27). The in situ proximity ligation assay (PLA)was performed
according to the manufacturer’s description (Duolink; Olink Bioscience,
Uppsala, Sweden). Fluorescence was then examined by confocal fluores-
cence microscopy (LSM510 Meta; Carl Zeiss Inc., Germany).
FIG 1 Tyrosine phosphorylation of TAZ by hyperosmotic stress-induced c-Abl activation. (A) mIMCD-3 cells were exposed to 300 and 400 mosmol/kg NaCl
for 4 h. Whole-cell extracts (WCE) were immunoprecipitated (IP) with anti-TAZ Ab, and immune complexes were immunoblotted (IB) with Abs against
phosphotyrosine (4G10), phosphoserine TAZ (pS89), andTAZ. (B) StablemIMCD-3 cells (mock and Flag-TAZ)were cultured under low-salt (150mosmol/kg),
normal (300 mosmol/kg), and hyperosmotic (400 mosmol/kg) conditions for 4 h and then incubated with Flag-M2 beads. TAZ immune complexes were
analyzed by immunoblotting with 4G10 and anti-TAZ Abs. (C) Total proteins were extracted frommIMCD-3 cells for immunoblotting of phosphorylated Abl
(pAbl), Abl, and actin. (D) Purified Flag-tagged TAZ was incubated with recombinant c-Abl kinase (rAbl) in the presence of radiolabeled ATP. The reaction
mixture was then analyzed by SDS-PAGE and radiography. Separately, the TAZ level was assessed by immunoblotting. (E) 293T cells were transfected with
Flag-TAZ, with () or without () the c-Abl expression vector. TAZ immune complexes were resolved by SDS-PAGE, followed by immunoblotting with 4G10.
(F) mIMCD-3 cells were infected with viruses expressing pSRP-Abl (siAbl), and whole-cell extracts were used for TAZ immunoprecipitation, followed by
immunoblotting with 4G10. (G) 293T cells were transfected with Flag-TAZ and c-Abl expression vectors and subsequently cultured in the presence of genistein
(GNS; 50 M) or STI-571 (STI; 10 M) for 1 h. TAZ immune complexes were analyzed by immunoblotting. (H) mIMCD-3 cells were stimulated with
hyperosmotic stress in the presence or absence of STI (10 M). TAZ immune complexes were subsequently analyzed with 4G10 and anti-TAZ Abs.
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Reporter gene assays. 293T cells were plated in a 6-well plate at 5 
105 cells/well and transiently transfectedwithNFAT5 andTAZ expression
vectors and an NFAT5/TonEBP-responsive element-linked luciferase
vector (pTonE-luc), as well as with pCMVgal as a transfection control.
Luciferase activitywas assayed using a Bright-Glo luciferase assay kit (Pro-
mega, Madison, WI). Relative luciferase units were calculated after nor-
malization with -galactosidase activity (Tropix, Bedford, MA).
Real-time PCR analysis. Total RNA was isolated from cells by use of
TRIzol (Gibco-BRL, Invitrogen) and used for reverse transcription for
cDNA synthesis (Invitrogen). Real-time PCRswere performedwith SYBR
green premix buffer and an ABI Prism 7300 sequence detector (Perkin-
Elmer Applied Biosystems, Foster City, CA). Relative expression levels
were determined after normalization to the threshold cycle (CT) values for
-actin. Gene-specific primers were as follows: for BGT1, 5=-CTGGGAG
AGACGGGTTTTGGGTATTACATC-3= and 5=-GGACCCCAGGTCGT
GGAT-3=; for SMIT, 5=-CCGGGCGCTCTATGACCTGGG-3= and 5=-CA
AACAGAGAGGCACCAATCG-3=; and for -actin, 5=-AGAGGGAAAT
CGTGCGTGAC-3= and 5=-CAATAGTGATGACCTGGCCGT-3=.
DNA pulldown assay. Cells were lysed with HKMG buffer (10 mM
HEPES, pH 7.9, 100 mM KCl, 5 mM MgCl2, 10% glycerol, 0.1% NP-40,
and 1mMdithiothreitol [DTT]) and incubated with biotinylated double-
stranded DNA and subsequently with streptavidin-agarose beads. Precip-
itates were washed with HKMG buffer three times and applied to SDS-
PAGE gels for immunoblot assay. The DNA sequences containing the
NFAT5/TonEBP-binding element were as follows: 5=-CTTGGTGGAAA
ATTACCGCTGGT-3= and 5=-AACCAGCGGTCCTTTTCCACCAA-3=.
Chromatin immunoprecipitation (ChIP) and quantitative real-
time PCR. Cells were formaldehyde cross-linked in a 1% solution for 10
min as described previously (15). Chromatin extracts were prepared and
incubated with anti-NFAT5 Ab at 4°C overnight, followed by incubation
with protein A/G-agarose beads (Pierce, Rockford, IL). Immune com-
plexes were sequentially washed and then heated to reverse the formalde-
hyde cross-linking of the protein and DNA complexes. The DNA frag-
ments were purified using a QIAquick PCR purification kit (Qiagen,
Hilden, Germany) and then used for PCR. Primers used were as follows:
SMIT-ChIP-F, 5=-TTGCGGCTTGGTGCAGCAGTC-3=; and SMIT-
ChIP-R, 5=-TCGCTCGGCACGCACCCGCTC-3=.
Establishment of stable cell lines by retroviral transduction. Virus-
producing Phoenix cells were cultured inDMEMsupplementedwith 10%
FBS and transfected with the TAZ-expressing retroviral vector by the cal-
cium phosphate transfection method. Viral supernatants were harvested
and added to mIMCD-3 or MEF cells in the presence of Polybrene (4
g/ml; Sigma-Aldrich) for 24 h. Stable cells were established by puromy-
cin resistance (Sigma-Aldrich).
Statistical analysis.All data are expressed asmeans standard errors of
the means (SEM). The statistical significance of the experimental results was
calculated by unpaired Student’s t test. Values of0.05 were considered sta-
tistically significant (*, P 0.05; **, P 0.005; and ***, P 0.0005).
RESULTS
Hyperosmotic stress induces tyrosine phosphorylation of TAZ
through c-Abl activation. In order to examine the effects of
osmotic stress on TAZ expression and activity, mouse renal med-
ullary cells, i.e., mIMCD-3 cells, were cultured under normal (300
mosmol/kg) and hyperosmotic (400 mosmol/kg) conditions.
Hyperosmotic stimulation of mIMCD-3 cells had no effect on
either expression of TAZ or phosphorylation of TAZ at serine 89
compared to that under normal conditions. However, phosphor-
ylation of TAZ on tyrosine residues was strikingly elevated under
hyperosmotic stress (observed using Ab 4G10) (Fig. 1A). This
observationwas confirmed by the finding that tyrosine phosphor-
ylation of ectopically expressed TAZ proteins was selectively en-
hanced by hyperosmolarity (Fig. 1B). Interestingly, endogenous
c-Abl tyrosine kinase was activated by hyperosmotic stimulation,
as demonstrated by the increased detection of phosphorylated but
not total c-Abl in response to hyperosmotic stress (Fig. 1C). To
determine whether c-Abl was an upstream tyrosine kinase for
TAZ, we performed an in vitro kinase assay using recombinant
c-Abl kinase. Immunoprecipitated TAZ protein was directly
phosphorylated by c-Abl in a cell-free system (Fig. 1D). Further-
more, coexpression of c-Abl with TAZ in 293T cells enhanced the
tyrosine phosphorylation of TAZ (Fig. 1E). In contrast, Abl
knockdown abolished TAZ phosphorylation induced by hyperos-
motic stimulation (Fig. 1F). Furthermore, the c-Abl-induced ty-
rosine phosphorylation was inhibited by genistein, a nonselective
tyrosine kinase inhibitor, and by STI-571, a c-Abl kinase-specific
inhibitor (Fig. 1G). Hyperosmotic stress also promoted tyrosine
phosphorylation of the endogenous TAZprotein alongwith c-Abl
activation, but it failed to induce tyrosine phosphorylation of TAZ
in the presence of STI-571 (Fig. 1H).
Tyrosine 316 of TAZ is the c-Abl phosphorylation site. We
next attempted to identify the c-Abl phosphorylation sites in TAZ.
Since TAZ contains 4 tyrosine residues (Y118, Y141, Y300, and
Y316), we first generated TAZ-specific phosphotyrosine Abs
(pY118, pY141, pY300, and pY316) by using synthetic TAZ pep-
tides containing the appropriate phosphotyrosines. The c-Abl-
induced tyrosine phosphorylation of TAZ was prominently de-
tected by 4G10 and by immunoblotting with the pY316 TAZ Ab
FIG 2 c-Abl-induced phosphorylation of TAZ at tyrosine 316. (A) 293T cells
were transfectedwith Flag-TAZand c-Abl expression vectors. TAZ immune com-
plexes were resolved by SDS-PAGE and immunoblotted with 4G10 and Abs
against pY116, pY141, pY300, pY316TAZ, andTAZ. (B) ParentalmIMCD-3 cells
were incubatedwithhyperosmolarmediumfor4h.EndogenousTAZproteinwas
immunoprecipitated and immunoblotted with pY316 TAZ or TAZAb. (C) Puri-
fied TAZ proteins were incubated with recombinant c-Abl kinase in the presence
of radiolabeled ATP. The reactionmixture was analyzed by SDS-PAGE and radi-
ography. (D) 293T cells were transfected withWT TAZ and Y316F TAZ, with or
without the c-Abl expression vector. Immune complexes were resolved and im-
munoblotted with 4G10, pY316 TAZ, and TAZ Abs. (E) mIMCD-3 cells were
stably transfectedwith the TAZ expression vector, and stable cells were selected in
the presence of puromycin. The cells were incubated under hyperosmotic stress
for 4 h, followed by immunoprecipitation and immunoblot analysis.
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but not by immunoblotting with the other Abs (Fig. 2A). We also
confirmed that hyperosmotic stress enhanced the tyrosine phos-
phorylation of endogenous TAZ selectively on Y316 (Fig. 2B).We
next constructed tyrosinemutants of TAZ (Y118F, Y141F, Y300F,
and Y316F) and performed the in vitro Abl kinase assay using
purified TAZ proteins. TAZ proteins, including the WT and the
Y118F, Y141F, and Y300F mutants, were phosphorylated by
c-Abl, but Abl phosphorylation was not observed in the Y316F
mutant (Fig. 2C). Overexpression of c-Abl with WT and Y316F
TAZ also increased the phosphorylation of WT TAZ but failed to
phosphorylate the Y316F mutant, as demonstrated by immuno-
blotting with the 4G10 and pY316 TAZAbs (Fig. 2D). In addition,
stable mIMCD-3 cells expressing Flag-tagged WT TAZ and its
tyrosine mutants were established and exposed to hyperosmotic
stress. Hyperosmotic stimulation induced tyrosine phosphoryla-
tion in WT, Y118F, Y141F, and Y300F TAZ proteins, but this
hyperosmotic stress-induced phosphorylation was impaired in
the Y316Fmutant (Fig. 2E), indicating that tyrosine 316 of TAZ is
the c-Abl phosphorylation site.
TAZ physically interacts with NFAT5 via hyperosmotic
stress-induced phosphorylation. To identify the functions of
phosphorylated TAZ in the hyperosmotic stress-mediated signal-
ing pathway, we examined the relationship between TAZ and
NFAT5, a key regulator of the hyperosmotic stress signaling path-
way (3, 27). To determine the interaction between TAZ and
NFAT5, we transiently expressed Flag-TAZ and NFAT5 together
with c-Abl in 293T cells. Interestingly, coimmunoprecipitation
and immunoblotting analysis demonstrated a physical interaction
betweenTAZ andNFAT5 (Fig. 3A).However, Y316Fmutant TAZ
was incapable of interacting with NFAT5 (Fig. 3A). In addition,
treatment of cells with STI-571 reduced the physical interaction
between TAZ andNFAT5 and diminished the tyrosine phosphor-
ylation of TAZ (Fig. 3B), indicating a tyrosine phosphorylation-
dependent interaction of TAZ with NFAT5. Since NFAT5 is also
phosphorylated at tyrosine 143 by c-Abl (11), we tested whether
tyrosine phosphorylation of NFAT5 was also essential for its in-
teraction with TAZ. The interaction of NFAT5 with TAZ was sus-
tained in Y143F mutant NFAT5, as indicated by the comparable
presence of WT and mutant NFAT5 in TAZ immune complexes
(Fig. 3C). Most importantly, analysis of endogenous TAZ im-
mune complexes verified that TAZ interacted with NFAT5 under
normal conditions and interacted more strongly under hyperos-
FIG 3 Physical interaction between phosphorylated TAZ and NFAT5. (A to C) 293T cells were transfected with c-Abl, Myc-tagged WT or mutated (Y143F or
MT)NFAT5, and Flag-taggedWTor Y316F TAZ, as indicated above each panel. (A)NFAT5 immune complexes were precipitated by incubation using anti-Myc
Ab and analyzed by SDS-PAGE and immunoblotting. (B) Cells were additionally treated with STI-571 (10 M) for 1 h before harvest. TAZ immune complexes
were analyzed by immunoblotting with Abs against Myc, pY316, and TAZ. (C) TAZ immune complexes were resolved by SDS-PAGE and subjected to
immunoblotting. (D to F)mIMCD-3 cells were stimulatedwith different tonicities for 4 h. (D) Endogenous TAZ immune complexes were precipitatedwith TAZ
Ab, followed by SDS-PAGE and immunoblotting with NFAT5 and pY316 Abs. (E) Separately, mIMCD-3 cells were cultured either in the presence or in the
absence of STI, and TAZ immune complexes were immunoblotted with NFAT Ab. (F) Tonicity-stimulated mIMCD-3 cells were fixed and incubated with TAZ
and NFAT5 Abs, followed by incubation with specific secondary Abs with PLA probes, using a Duolink in situ PLA kit. Samples were observed under a confocal
microscope, and the number of spots per cell was measured. nd, not determined.
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motic stress, in a tyrosine phosphorylation-dependent manner
(Fig. 3D).However, treatment of cells with STI-571 attenuated the
interaction between TAZ and NFAT5 under hypertonic condi-
tions (Fig. 3E). Furthermore, the in situ PLA system visualized the
individual TAZ-NFAT5 interaction in the nuclei of mIMCD-3
cells cultured in normal or hyperosmolarmediumbut not in those
cultured in low-salt (150 mosmol/kg) medium (Fig. 3F).
TAZ suppresses DNA-binding and transcriptional activities
of NFAT5. Next, we determined the effects of the TAZ-NFAT5
interaction on NFAT5 activity. Transcriptional activity of NFAT5
was assessed with an NFAT5/TonEBP-responsive luciferase re-
porter gene (pTonE-luc) in the presence or absence of TAZ.
Ectopic expression of NFAT5 increased the luciferase activity of
pTonE-luc, but coexpression of TAZ significantly suppressed this
activity, in a dose-dependent manner (Fig. 4A). Furthermore, the
NFAT5-induced reporter activity was inhibited by overexpression
of WT or Y118F TAZ, whereas Y316F TAZ did not suppress
NFAT5 activity (Fig. 4B), consistent with the inability of Y316F
TAZ to interact with NFAT5. The TAZ-mediated suppression of
NFAT5 transcriptional activity led us to examine the DNA-bind-
ing activity of NFAT5 in the presence of TAZ. A DNA pulldown
assay revealed that NFAT5 bound directly to a DNA sequence
containing the NFAT5/TonEBP-binding element, and this DNA-
NFAT5 association was markedly inhibited by overexpression of
WT TAZ but not by overexpression of the Y316F mutant (Fig.
4C). More significantly, ChIP assay demonstrated that NFAT5
bound to the SMIT promoter region in response to hyperosmo-
larity. The NFAT5-DNA association was suppressed by the over-
expression of WT TAZ but not by overexpression of Y316F TAZ
(Fig. 4D). More significantly, NFAT5 binding to the SMIT pro-
moter was augmented in TAZ-deficient cells, as evidenced by
ChIP and real-time PCR analysis (Fig. 4E and F). These results
FIG 4 Suppression of NFAT5 activity by TAZ. (A) 293T cells were transfected with NFAT5 and different amounts of TAZ expression vector together with
pTonE-luc. pCMVgal was used as a control. NFAT5 and TAZ expression was determined by immunoblot analysis. Relative luciferase activity was calculated
after normalization to-galactosidase activity. (B) 293T cells were transfected withNFAT5 and TAZ (WTor Y316F) expression vectors together with pTonE-luc
and pCMVgal. Reporter activity was calculated from 3 independent experiments and expressed as the mean. (C) NFAT5 was overexpressed in 293T cells
together withWT or Y316F TAZ.Whole-cell extracts were incubated with biotinylated double-stranded DNA containing the NFAT5/TonEBP-binding element
for 1 h and subsequently incubatedwith streptavidin-agarose beads for an additional 2 h, followed by SDS-PAGE and immunoblotting. DNA-binding complexes
were analyzed with NFAT5 and TAZ Abs. (D) mIMCD-3 or stable mIMCD-3 cells (mock [con], TAZ, and Y316F TAZ) were stimulated with either 150 or 400
mosmol/kg for 4 h. Whole-cell extracts were immunoprecipitated with NFAT5 Ab, and chromatin was analyzed by a PCR using specific primers for the
NFAT5-binding element within the SMIT gene promoter. (E) mIMCD-3 cells (shcon and shTAZ) were cultured under 400 mosmol/kg and harvested for ChIP
and real-time PCR. (F) WT and KOMEF cells were stimulated with 400 mosmol/kg for 4 h, and cells were analyzed by ChIP and quantitative PCR. *, P 0.05;
**, P 0.005; ***, P 0.0005.
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indicate that the TAZ-NFAT5 interaction suppresses the tran-
scriptional activity of NFAT5 by inhibiting the DNA-binding ac-
tivity of NFAT5.
ExpressionofBGT1andSMIT isnegatively regulatedbyTAZ
expression. Since TAZ suppressed the DNA-binding and tran-
scriptional activities of NFAT5, we investigated the effects of TAZ
overexpression on the expression of endogenous NFAT5 target
genes, such as the BGT1 and SMIT genes. The TAZ protein level
was increased in stable TAZ cells compared to control mIMCD-3
cells, whereasNFAT5 expressionwas comparable between control
and stable TAZ cells and unchanged by tonicity challenges (Fig.
5A). Interestingly, the relative expression of BGT1 and SMIT was
drastically increased by hyperosmotic stimulation in control cells,
but this increase was significantly attenuated by the overexpres-
sion of TAZ (Fig. 5B). Conversely, wemeasured the levels of BGT1
and SMIT in TAZ knockdown cells (shTAZ cells) (Fig. 5C). Hy-
perosmotic stress consistently increased the expression of BGT1
and SMIT in control (shcon) cells. However, the levels of BGT1
and SMIT were substantially elevated by reductions in TAZ ex-
pression under both normal and hyperosmolar conditions (Fig.
5D). These results suggest that the TAZ expression level may be
important for fine-tuning NFAT5 activity induced by hyperos-
motic stimulation.
Restoration of TAZ, but not Y316F TAZ, in TAZ-deficient
cells leads to suppression of enhanced NFAT5 activity. We
wanted to confirm that the increase in NFAT5 activity caused by
the lack of TAZ could be reversed directly by TAZ restoration. For
the reintroduction of TAZ or the Y316F mutant, MEF cells were
isolated from WT and KO mice, and cellular responses were ex-
amined under different osmotic stresses. TAZ expression in the
WT and KOMEF cells was verified by immunoblot analysis (Fig.
6A). MEF cells were then transfected with the pTonE-luc reporter
gene and challenged with media of different osmolarities. Hyper-
FIG 5 Inhibitory effects of TAZ on NFAT5-induced gene expression. (A and
B) Stable TAZ transfectants (TAZ) and control cells (CON) were cultured
under different tonicity conditions for 4 h. (A) Expression of TAZ andNFAT5
was determined by immunoblotting. (B) Total RNA was isolated from cells
and subjected to reverse transcription and real-time PCR formeasuring BGT1
and SMIT1 levels. Relative expression levels were calculated after normaliza-
tion against -actin levels. (C and D) TAZ knockdown (shTAZ) and control
(shcon) cells were established and stimulated with normal and hyperosmolar
conditions for 4 h. (C) Protein levels of TAZ, NFAT5, and actin were con-
firmed by immunoblotting. (D) Relative mRNA levels of BGT1 and SMIT
were determined by real-time PCR. *, P 0.05; **, P 0.005.
FIG 6 Resuppression of NFAT5 activity by restored TAZ, but not Y316F TAZ, in TAZ KO cells. (A) TAZ expression in WT and KOMEF cells was determined
by immunoblotting. (B) WT and KOMEF cells were transfected with reporter genes (pTonE-luc and pCMVgal) and treated with different tonicities for 24 h.
(C) Total RNAswere harvested fromWT andKOMEF cells incubated under hyperosmolar conditions and used formeasuringmRNA levels of BGT1 and SMIT.
(D) TAZ KOMEF cells were transfected withWT or Y316F TAZ expression vector together with reporter gene vectors (pTonE-luc and pCMVgal). Cells were
then challenged with normal or hyperosmolar medium for 24 h. Reporter activities (relative light units [RLU]) in panels B and D were calculated after
normalizationwith-galactosidase activity and are expressed asmeans SEM for three independent experiments. (E) KOMEF cells were restoredwithWT and
Y316F TAZ expression vectors and subsequently treated with hyperosmolar medium. Total RNA was used for reverse transcription and real-time PCR analysis.
(F) Total RNAs were isolated from the kidneys of WT and KOmice (10 to 12 weeks old; n 4), followed by reverse transcription and real-time PCR analysis. *,
P 0.05; **, P 0.005; ***, P 0.0005.
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osmotic stimulation increased the reporter activity in WT MEF
cells but had a much greater effect on the TAZ KO cells (Fig. 6B).
Consistently, the BGT1 mRNA level was much greater in hyper-
osmolarity-stimulated KO cells than in WT cells (Fig. 6C). Next,
the increased pTonE-luc activity in TAZKO cells reverted to basal
levels upon restoration of WT TAZ. However, introduction of
Y316F TAZ was much less effective at inhibiting reporter activity
(Fig. 6D). The endogenous mRNA level of SMIT was accordingly
regulated by the restoration ofWTTAZor the Y316Fmutant (Fig.
6E). Lastly, we attempted to measure the in vivo effect of TAZ
deficiency on expression levels of NFAT5-mediated osmoregula-
tory genes, as TAZ suppressed NFAT5 activity in vitro. Despite
severe morphological defects in the kidneys of TAZ KO mice,
expression of SMIT and BGT1 was significantly increased in the
renal medulla of TAZ KO kidneys compared to that in WT kid-
neys (Fig. 6F).
DISCUSSION
Our results demonstrate that TAZ undergoes tyrosine phosphor-
ylation at tyrosine 316 by c-Abl kinase upon hyperosmotic stim-
ulation and then specifically interacts with and suppresses the
transcriptional activity of NFAT5.While ectopic TAZ overexpres-
sion suppresses the transcription of NFAT5 target genes, such as
the SMIT and BGT1 genes, TAZ deficiency increases the expres-
sion of SMIT and BGT1 in vitro and in vivo. Collectively, our data
are the first to demonstrate that TAZ functions as a suppressor of
NFAT5 activity in response to hyperosmotic stress.
Interestingly, TAZ selectively associates with and modulates
the activity of NFAT5 in a tyrosine phosphorylation-dependent
manner. Hyperosmotic stress activates multiple mitogen-acti-
vated kinases (1), protein kinase A (9), and tyrosine kinases such
as Syk and Yes (25, 31), which then modulate the expression of
genes required for osmotic regulation. TAZ is also phosphorylated
by Ser/Thr protein kinases at serine residues (19, 20), but its S89
phosphorylation was not affected by hyperosmotic stimulation.
Recently, c-Abl was identified as the kinase responsible for hyper-
osmotic stress signaling via NFAT5 phosphorylation (11). Gal-
lazzini et al. observed that c-Abl was activated within 1 h upon
stimulation at 500 mosmol/kg and that the activated c-Abl phos-
phorylated NFAT5 on tyrosine 143 and stimulated its nuclear lo-
calization and transcriptional activity (11). Our results demon-
strate that TAZ, like NFAT5, is a novel substrate for c-Abl in
kidney cells stimulated with hyperosmolarity for 4 h. However,
phosphorylated TAZ subsequently suppresses NFAT5 activity
through a phosphorylation-dependent physical interaction. In-
terestingly, c-Abl-induced tyrosine phosphorylation of TAZ is a
prerequisite for suppressing NFAT5 activity, whereas c-Abl-me-
diated NFAT5 phosphorylation is not essential for interaction of
NFAT5 with TAZ. These findings suggest that c-Abl may have
dual roles in timely regulation of renal tonicity by accelerating and
decelerating NFAT5 activity through sequential phosphorylation
of NFAT5 and TAZ. The detailed mechanisms and in vivo impli-
cations of c-Abl-mediated NFAT5 and TAZ regulation remain to
be uncovered. In addition, a few punctate spots of TAZ-NFAT5
complexes were visualized in the nucleus, indicating the fine-tun-
ing of NFAT5 activity by phosphorylated TAZ.
Our results suggest that TAZ deficiencymay cause constitutive
activation of NFAT5 in renal medullary cells and thus lead to
cellular resistance to hyperosmotic stress-induced damage. How-
ever, TAZ KO mice die shortly after birth, due to developmental
defects in multiple organs; the few viable TAZ KO mice display
multicystic kidneys with polyuria (24). Despite abnormal renal
structure or function, the renal medullas of TAZ KOmice express
significantly higher levels of BGT1 and SMIT than those of WT
mice. Most importantly, however, the in vivo importance of TAZ-
mediated NFAT5 suppression after exposure to hyperosmotic
stress should be verified in viablemicewith kidney-specific knock-
out of TAZ. On the other hand, NFAT5 has been characterized
extensively as having hyperosmolarity-independent and tissue-
specific functions in a variety of cell types (12, 18, 32). NFAT5 KO
mice are embryonic lethal due to impaired cardiac development
and function, and the embryos display renal atrophy (21, 23);
thus, it appears that NFAT5 is essential for heart and kidney de-
velopment. Therefore, TAZ-mediated NFAT5 regulation may
also be important in regulating heart and kidney development,
but its detailed molecular functions and mechanisms are poorly
understood. Together, our results suggest that TAZ functions in
fine-tuning NFAT5 activity through tyrosine phosphorylation
and contributes to cellular adaptation to hyperosmotic stress.
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